Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia
- Resource Type
- Article
- Authors
- Sun, Shan-Liang; Wu, Jia-Zhen; Wang, Jing-Jing; Zhou, Hai; Zhang, Chen-Qian; Tong, Zhen-Jiang; Wang, Yi-Bo; Sha, Jiu-Kai; Wang, Qing-Xin; Liu, Jia-Chuan; Zheng, Xin-Rui; Li, Qing-Qing; Zhang, Meng-Yuan; Yang, Jin; Wei, Tian-Hua; Wang, Zi-Xuan; Yu, Yan-Cheng; Ding, Ning; Leng, Xue-Jiao; Xue, Xin; Li, He-Min; Dai, Wei-Chen; Yin, Xiao-Ying; Yang, Ye; Duan, Jin-Ao; Li, Nian-Guang; Shi, Zhi-Hao
- Source
- In Biomedicine & Pharmacotherapy 31 December 2023 169
- Subject
- Language
- ISSN
- 0753-3322